Bio Green Med Solution, Inc.
BGMS· Nasdaq
Released Mar 30, 2026, after the close
10-K filed Mar 30, 2026, 89 days after period end · 0001493152-26-013669
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $31.00K | $0.00 |
| Net Income | -$611.00K |
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR
| -$3.05M |
| -$5.27M |
| -$7.42M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.